UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 26, 2015	Sep. 27, 2014
Cash flows from operating activities:
Net loss	$ (30.6)	$ (50.2)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation expense	37.8	31.6
Amortization expense, including increase to cost of products sold for inventory acquired in business combinations	49.5	45.5
Non-cash impairment charges	1.2	80.4
Loss from debt retirement	14.8	2.3
Non-cash interest expense, net	2.3	1.8
Non-cash share-based compensation expense	3.7	4.9
Excess tax benefit on share-based awards	(0.5)	(6.4)
Loss (gain) on sale of assets	3.0	(0.3)
Deferred income tax benefit	(16.5)	(44.3)
Changes in certain assets and liabilities, net of effects from acquisitions:
Accounts receivable, net	(26.0)	(64.8)
Inventories	(14.0)	(85.0)
Prepaid and other current assets	(2.8)	2.9
Accounts payable	(12.8)	74.6
Accrued expenses, taxes, and deferred revenue	19.3	26.7
Long-term assets, liabilities and other, net	(7.8)	(2.1)
Total adjustments to net loss	51.2	67.8
Net cash provided by operating activities	20.6	17.6
Cash flows from investing activities:
Capital expenditures	(29.1)	(27.7)
Net cash paid for businesses acquired and dispositions	(64.7)	(254.9)
Proceeds from the sale of property and equipment	0.1	1.6
Change in restricted cash and marketable securities	0.2	0.3
Other, net	(0.4)	(1.4)
Net cash used in investing activities	(93.9)	(282.1)
Cash flows from financing activities:
Proceeds from ABL and other borrowings	340.7	142.4
Payment of ABL and other borrowings	(293.2)	(144.8)
Redemption of the 10% Senior Notes due 2018, including redemption premium	(262.5)	0.0
Net proceeds from borrowings under the senior secured term loan facility due 2020	261.8	349.1
Redemption of the senior secured term loan facility due 2017	0.0	(93.0)
Fees paid in connection with debt facilities	(2.7)	(6.3)
Net use from equity transactions	(1.9)	(4.0)
Excess tax benefit on share-based awards	0.5	6.4
Other, net	0.0	0.0
Net cash provided by financing activities	42.7	249.8
Net change in unrestricted cash and cash equivalents	(30.6)	(14.7)
Unrestricted cash and cash equivalents at the beginning of the period	58.4	80.9
Unrestricted cash and cash equivalents at the end of the period	$ 27.8	$ 66.2